Decisive Diagnostics is open to various mutually beneficial forms of collaboration, including research collaborations, co-development of products in our pipeline, out-licensing and fee-based services. Please contact us to find out more about our varied portfolio of patents and pending patents as well as opportunities to license our human cell lines.
Patent Portfolio
- Bladder Cancer
- Colon Cancer
- Human DNA Reference Controls
- Warfarin Dosing
- Oligonucleotide Libraries
- Identifying Sequence Differences in a Reduced Complexity Genome
Cell Lines
- 24 human cell lines
- Obtained from properly consented donors
- Characterized for important drug metabolism genes
- Appropriate for use in pharmacogenomic assays, aCGH applications, ADME studies, and lab proficiency tests employing genomic DNA
- Exclusive and non-exclusive licenses available
